These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2424653)
1. The mechanism of enhancement of natural killer cell activity by soluble streptococcal products. Lapham C; John PA; Tomar RH Clin Immunol Immunopathol; 1986 Aug; 40(2):335-46. PubMed ID: 2424653 [TBL] [Abstract][Full Text] [Related]
2. Peripheral blood mononuclear cells from AIDS patients release but do not respond to antigen-stimulated NK-activating lymphokines. Lapham CK; Sacks LV; Tomar RH J Clin Lab Anal; 1989; 3(1):8-13. PubMed ID: 2523964 [TBL] [Abstract][Full Text] [Related]
3. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980 [TBL] [Abstract][Full Text] [Related]
4. Studies of the enhancement of natural cytotoxicity by the streptococcal immunopotentiator OK432. Christmas SE; Meager A; Moore M Int J Immunopharmacol; 1986; 8(1):83-92. PubMed ID: 2420735 [TBL] [Abstract][Full Text] [Related]
5. Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an anti-tumor streptococcal preparation, OK-432. Shitara K; Ichimura O; Mitsuno T; Osawa T J Immunol; 1985 Feb; 134(2):1039-47. PubMed ID: 2578148 [TBL] [Abstract][Full Text] [Related]
6. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432. Wakasugi H; Kasahara T; Minato N; Hamuro J; Miyata M; Morioka Y J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282 [TBL] [Abstract][Full Text] [Related]
7. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones. van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399 [TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF). Wright SC; Bonavida B J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909 [TBL] [Abstract][Full Text] [Related]
9. Natural killer (NK) cell activating factor produced by a human T-cell hybridoma. Kobayashi Y; Yoshimatsu K; Osawa T Microbiol Immunol; 1991; 35(11):981-93. PubMed ID: 1775099 [TBL] [Abstract][Full Text] [Related]
10. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism. Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102 [TBL] [Abstract][Full Text] [Related]
11. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts. Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628 [TBL] [Abstract][Full Text] [Related]
12. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist. Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315 [TBL] [Abstract][Full Text] [Related]
13. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide. Munakata T; Semba U; Shibuya Y; Kuwano K; Akagi M; Arai S J Immunol; 1985 Apr; 134(4):2449-55. PubMed ID: 3919096 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation. Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756 [TBL] [Abstract][Full Text] [Related]
15. Induction of T-cell proliferation and enhancement of NK activity by supernatants from Con A-stimulated human peripheral blood mononuclear cells: a new lymphokine. Rosloniec EF; Cleveland RP; Kaufman DB Cell Immunol; 1986 Apr; 99(1):170-81. PubMed ID: 2428528 [TBL] [Abstract][Full Text] [Related]
16. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma. Platsoucas CD Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722 [TBL] [Abstract][Full Text] [Related]
17. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro. Iho S; Yamamoto T; Takahashi T; Yamamoto S J Immunol; 1999 Oct; 163(7):3642-52. PubMed ID: 10490958 [TBL] [Abstract][Full Text] [Related]
18. Staphylococcal enterotoxin B activates purified NK cells to secrete IFN-gamma but requires T lymphocytes to augment NK cytotoxicity. D'Orazio JA; Burke GW; Stein-Streilein J J Immunol; 1995 Feb; 154(3):1014-23. PubMed ID: 7529788 [TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF). Wright SC; Bonavida B J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]